Patent · US Active

Method for treating eye disease or conditions affecting the posterior segment of the eye

US9192567B2 · kind B2 · utility

1Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 2007
Grant dateNov 24, 2015
Priority date
Expiry dateJun 10, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described is the use of prodrug for the manufacture of a medicament useful for treating an ocular disease affecting the posterior segment of the eye, in a subject in need thereof, wherein the prodrug is a composition injected into the vitreous body, and the frequency of injections does not exceed one injection per month.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.